Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy AdultsCompleted
NCT06190561Phase 1Updated Jun 13, 2024
Sponsor: Pfizer
Healthy
United States
Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in VitiligoCompleted
NCT05298033Phase 2Updated Jun 12, 2024
Sponsor: University of Colorado, Denver
Vitiligo
United States
Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of AgeCompleted
NCT05310084Phase 3Updated Jun 12, 2024
Sponsor: BioNTech SE
SARS-CoV-2 Infection · COVID-19
Australia, New Zealand
Prospective Study of Rapamycin for the Treatment of SLECompleted
NCT00779194Phase 2Updated Jun 12, 2024
Sponsor: State University of New York - Upstate Medical University
Systemic Lupus Erythematosus (SLE)
United States
Trial for Treatment Refractory Trigeminal NeuralgiaTerminated
NCT03941834Phase 2Updated Jun 10, 2024
Sponsor: Pfizer
Trigeminal Neuralgia
United States
A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD)Completed
NCT04983264Phase 1Updated Jun 10, 2024
Sponsor: Pfizer
Sickle Cell Disease
United States
Pharmacokinetics and Safety of RV521 FormulationsCompleted
NCT04065698Phase 1Updated Jun 7, 2024
Sponsor: Pfizer
Respiratory Syncytial Virus Infections
United Kingdom
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in AdultsCompleted
NCT03732638Phase 2, Phase 3Updated Jun 7, 2024
Sponsor: Pfizer
Migraine
United States
Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast CancersActive Not Recruiting
NCT03911973Phase 1, Phase 2Updated Jun 7, 2024
Sponsor: Kari Wisinski
TNBC - Triple-Negative Breast Cancer
United States
Real-World Effectiveness of Palbociclib in Combination With an Aromatase InhibitorCompleted
NCT05361655N/AUpdated Jun 7, 2024
Sponsor: Pfizer
Metastatic Breast Cancer
United States
A Preliminary Study to Evaluate PF-07264660 in Healthy ParticipantsCompleted
NCT05496738Phase 1Updated Jun 6, 2024
Sponsor: Pfizer
Healthy
United States
Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy ParticipantsCompleted
NCT05263921Phase 1Updated Jun 6, 2024
Sponsor: Pfizer
Bioavailability
United States
Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic DermatitisCompleted
NCT04668066Phase 1Updated Jun 3, 2024
Sponsor: Pfizer
Atopic Dermatitis
United States
A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With FoodCompleted
NCT05498701Phase 1Updated Jun 3, 2024
Sponsor: Pfizer
Healthy
Canada
A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine VepdegestrantCompleted
NCT06275841Phase 1Updated Jun 3, 2024
Sponsor: Pfizer
Healthy
United States
Comparison of Tacrolimus and Myfortic Versus Tacrolimus and SirolimusWithdrawn
NCT01038505Phase 4Updated Jun 3, 2024
Sponsor: University of Miami
Living Donor Kidney Transplants Patients
A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy ParticipantsCompleted
NCT05067439Phase 1Updated May 31, 2024
Sponsor: Pfizer
Healthy Participants
United States
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant WomenCompleted
NCT04766086Phase 2Updated May 24, 2024
Sponsor: Pfizer
Group B Streptococcus Infections
United States
A Study to Compare Two Tablet Forms of Tafamidis in Healthy ParticipantsCompleted
NCT05482308Phase 1Updated May 23, 2024
Sponsor: Pfizer
Healthy
Belgium
DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial FibrillationCompleted
NCT05838781NAUpdated May 22, 2024
Sponsor: Bristol-Myers Squibb
Atrial Fibrillation · Atrial Flutter
Sweden
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple MyelomaCompleted
NCT05565391N/AUpdated May 21, 2024
Sponsor: Pfizer
Multiple Myeloma
United States
Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims DataCompleted
NCT05438888N/AUpdated May 20, 2024
Sponsor: Pfizer
Non-valvular Atrial Fibrillation
Japan
Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular DisordersTerminated
NCT05262517Phase 3Updated May 16, 2024
Sponsor: Pfizer
Temporomandibular Disorders (TMD)
United States
Acromegaly: Balance, Falls and Fracture RiskCompleted
NCT05752825N/AUpdated May 16, 2024
Sponsor: Christian Alexander H Rosendal
Acromegaly
Denmark
A Study to Learn About Effect of Sisunatovir in Healthy Adult Male ParticipantsCompleted
NCT05873764Phase 1Updated May 16, 2024
Sponsor: Pfizer
Respiratory Syncytial Virus Infections
United States

Previous page Next page